Cir's 4th Tysabri Update
Cir's 4th infusion of Tysabri went well. No video again - hopefully next time. Also, no adverse reactions and still on an uphill as far as feeling more energetic. I feel (we both do) like things will continue to get better the longer he's on the medication.
We met another Tysabri patient and she had just come back after having a baby (her third). Her plan would be to take a pregnancy test before coming in for each infusion. If it was negative, she would come in, if positive, she would forgo the infusion. This is what had happened 9 months earlier.
She was off the medication for each of her children and for a few weeks afterward while she nursed the babies. She has been on Tysabri for 11 years and looks great. I'm not sure if she had any mobility problems, however, the day we saw her, she wasn't using a cane or walker.
I know that pregnancy is "good" for women when it comes to multiple sclerosis symptoms. However, I can't help but wonder if the Tysabri also played a hand in how well she's doing afterward.
I do hope that Cir does well on this medication and the JC virus stays at bay. So far so good... Update next month :)
Click here to post comments
Join in and write your own page! It's easy to do. How? Simply click here to return to Tysabri Updates.
"Life in Spite of MS is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com."
We'd also like you to know it doesn't cost one cent more when you click through the links here on our blog. Not one single penny. And we willl make a little extra cash when you do click through. We'll be ever so appreciative. You also have our word that we'll only link to things that we would use ourselves, (or wish we could have or use.
Cir & Akrista
You are reading original content written by Akrista or Cir L'Bert of Life in Spite of MS. If you enjoyed reading this blog, please consider following us on Facebook, Twitter, Pinterest, and Instagram. See you there!